irinotekan actavis 20 mg/ml koncentrat za raztopino za infundiranje
actavis group hf - irinotekan - koncentrat za raztopino za infundiranje - irinotekan 17,33 mg / 1 ml - irinotekan
irinotekan teva 20 mg/ml koncentrat za raztopino za infundiranje
teva pharma b.v. - irinotekan - koncentrat za raztopino za infundiranje - irinotekan 17,33 mg / 1 ml - irinotekan
irinotekanijev klorid lek 20 mg/ml koncentrat za raztopino za infundiranje
lek d.d. - irinotekan - koncentrat za raztopino za infundiranje - irinotekan 17,33 mg / 1 ml - irinotekan
irinotekanijev klorid lek 20 mg/ml koncentrat za raztopino za infundiranje
lek d.d. - irinotekan - koncentrat za raztopino za infundiranje - irinotekan 17,33 mg / 1 ml - irinotekan
irinotekan teva 20 mg/ml koncentrat za raztopino za infundiranje
actavis group hf - irinotekan - koncentrat za raztopino za infundiranje - irinotekan 17,33 mg / 1 ml - irinotekan
irinotekan teva 20 mg/ml koncentrat za raztopino za infundiranje
actavis group hf - irinotekan - koncentrat za raztopino za infundiranje - irinotekan 17,33 mg / 1 ml - irinotekan
irinotekan teva 20 mg/ml koncentrat za raztopino za infundiranje
actavis group hf - irinotekan - koncentrat za raztopino za infundiranje - irinotekan 17,33 mg / 1 ml - irinotekan
onzeald
nektar therapeutics uk limited - etirinotekan pegol - neoplazme dojke - antineoplastična sredstva - zdravljenje raka dojke z možganski zasevki.
lonsurf
les laboratoires servier - trifluridine, tipiracil hidroklorid - kolorektalne neoplazme - antineoplastična sredstva - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
irinotekan ebewe 20 mg/ml koncentrat za raztopino za infundiranje
ebewe pharma - irinotekan - koncentrat za raztopino za infundiranje - irinotekan 17,33 mg / 1 ml - irinotekan